Cue Health CEO on FDA emergency authorization for Covid at-home test

The FDA has granted emergency use authorization for Cue Health's rapid Covid test, making it the first molecular test for Covid-19 authorized for at-home use without a prescription. Ayub Khattak, Cue Health co-founder and CEO, joined "Squawk Box" on Monday to discuss.